Technology: Viewpoints: FDA Regulatory Considerations on Approvals for Artificial Intelligence



Washington, D.C. partners Ben Haas and Elizabeth Richards discuss the FDA’s efforts to modernize the regulatory pathway to marketing to account for artificial …



source

Post Author: Latham & Watkins